Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Sleep and quality of life improvements after endoscopic sinus surgery in patients with chronic rhinosinusitis.
Cutting edge: a single, essential hydrogen bond controls the stability of peptide-MHC class II complexes.
Candidiasis, Chronic Mucocutaneous
bcl-2-Associated X Protein
Subcutaneous and sublingual immunotherapy for allergic rhinitis: what is the evidence?
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Subcutaneous and sublingual immunotherapy for allergic rhinitis: what is the evidence?
Subcutaneous and sublingual immunotherapy for allergic rhinitis: what is the evidence? Am J Rhinol Allergy. 2012 Jan-Feb; 26(1):18-22.
View in:
PubMed
subject areas
Administration, Sublingual
Animals
Clinical Trials as Topic
Desensitization, Immunologic
Evidence-Based Medicine
Humans
Injections, Subcutaneous
Rhinitis, Allergic, Perennial
Rhinitis, Allergic, Seasonal
United States
authors with profiles
Rodney J. Schlosser